Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Mangoceuticals, Inc. ( (MGRX) ).
On July 21, 2025, Mangoceuticals, Inc. amended a $100,000 promissory note with The Tiger Cub Trust, controlled by CEO Jacob D. Cohen, to a convertible note allowing conversion to common stock and removed mandatory prepayment terms. Additionally, the company engaged in an equity purchase agreement with Platinum Point Capital, selling shares for $409,367 to support its financial strategy.
More about Mangoceuticals, Inc.
Mangoceuticals, Inc. operates in the pharmaceutical industry, focusing on developing and marketing health-related products. The company is involved in fundraising and financial agreements to support its operations and growth.
Average Trading Volume: 250,822
Technical Sentiment Signal: Sell
Current Market Cap: $17.35M
See more insights into MGRX stock on TipRanks’ Stock Analysis page.